These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19557469)

  • 21. The role of adjuvant chemotherapy for locally advanced bladder cancer.
    Lehmann J; Retz M; Stöckle M
    World J Urol; 2001 Apr; 19(2):133-40. PubMed ID: 11374316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [First line therapy for locally advanced or metastatic urothelial cancer : A randomized double blind phase III multicenter study on adjuvant nivolumab therapy versus placebo in patients with invasive high-risk urothelial cancer (CheckMate 274)-AB 58/17 of the AUO].
    Rexer H; Ohlmann CH; Gschwend J;
    Urologe A; 2017 Oct; 56(10):1331-1332. PubMed ID: 28779222
    [No Abstract]   [Full Text] [Related]  

  • 24. Perioperative chemotherapy in advanced bladder cancer: part I. Neoadjuvant treatment.
    Goebell PJ; Otto T; Rübben H
    Onkologie; 2003 Aug; 26(4):361-5. PubMed ID: 12972704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy for bladder cancer.
    Sonpavde G; Lerner SP
    Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant cisplatin for advanced bladder cancer.
    Advanced Bladder Cancer Overview Collaboration
    Cochrane Database Syst Rev; 2000; (2):CD001426. PubMed ID: 10796791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging drugs for urothelial (bladder) cancer.
    Cumberbatch K; He T; Thorogood Z; Gartrell BA
    Expert Opin Emerg Drugs; 2017 Jun; 22(2):149-164. PubMed ID: 28556678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant chemotherapy of bladder cancer.
    Freiha FS; Torti FM
    Prog Clin Biol Res; 1988; 260():545-9. PubMed ID: 3129738
    [No Abstract]   [Full Text] [Related]  

  • 29. Advanced urothelial carcinoma: moving the field forward.
    Milowsky MI
    Oncology (Williston Park); 2013 Mar; 27(3):233-4, C3. PubMed ID: 23687795
    [No Abstract]   [Full Text] [Related]  

  • 30. Current status of chemotherapy for urothelial tract tumors.
    Sternberg CN; Scher HI
    Oncology (Williston Park); 1987 Jul; 1(5):41-50, 60. PubMed ID: 3079483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy for advanced urothelial cancer.
    Yagoda A
    Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
    [No Abstract]   [Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care?
    Mazhar D; Ali N; Ngan S
    Future Oncol; 2007 Feb; 3(1):5-8. PubMed ID: 17280495
    [No Abstract]   [Full Text] [Related]  

  • 33. Targeted agents in second-line bladder cancer therapy.
    Gerullis H; Otto T; Ecke TH
    Anticancer Drugs; 2012 Nov; 23(10):1003-15. PubMed ID: 22914698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
    Morales-Barrera R; Suárez C; de Castro AM; Racca F; Valverde C; Maldonado X; Bastaros JM; Morote J; Carles J
    Cancer Treat Rev; 2016 Nov; 50():208-216. PubMed ID: 27743530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma.
    Tabayoyong W; Li R; Gao J; Kamat A
    Urol Clin North Am; 2018 May; 45(2):155-167. PubMed ID: 29650132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a role for induction therapy for locally advanced bladder cancer?
    Soloway MS
    Urology; 1987 Jun; 29(6):577-83. PubMed ID: 3576880
    [No Abstract]   [Full Text] [Related]  

  • 37. Neo-adjuvant and adjuvant chemotherapy in bladder cancer.
    D'Auria G; Ciprotti M; Conte D; Iacovelli R; Palazzo A; Pellegrino A; Cortesi E
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi162-3. PubMed ID: 17591814
    [No Abstract]   [Full Text] [Related]  

  • 38. [50 years of systemic therapy of urinary bladder cancer].
    Retz M; von Amsberg G; Horn T; Gschwend JE; Maisch P
    Aktuelle Urol; 2019 Aug; 50(4):358-365. PubMed ID: 31242517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Missing the target" in urothelial cancer.
    Dreicer R
    Oncology (Williston Park); 2013 Mar; 27(3):227, 233. PubMed ID: 23687794
    [No Abstract]   [Full Text] [Related]  

  • 40. p53 and treatment of bladder cancer.
    Cote RJ; Esrig D; Groshen S; Jones PA; Skinner DG
    Nature; 1997 Jan; 385(6612):123-5. PubMed ID: 8990112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.